|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1993-3-22
|
|
pubmed:abstractText |
On the basis of preliminary results achieved with a high-dose cisplatin regimen including glutathione as chemoprotector, the efficacy and toxicity of the new regimen was further evaluated in a larger series of patients with advanced ovarian cancer (stage III and IV).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
55-61
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8435364-Adult,
pubmed-meshheading:8435364-Aged,
pubmed-meshheading:8435364-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8435364-Cisplatin,
pubmed-meshheading:8435364-Cyclophosphamide,
pubmed-meshheading:8435364-Female,
pubmed-meshheading:8435364-Glutathione,
pubmed-meshheading:8435364-Humans,
pubmed-meshheading:8435364-Middle Aged,
pubmed-meshheading:8435364-Ovarian Neoplasms,
pubmed-meshheading:8435364-Prognosis,
pubmed-meshheading:8435364-Survival Rate,
pubmed-meshheading:8435364-Treatment Outcome
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer.
|
|
pubmed:affiliation |
Istituto Nazionale per lo Studio e la Cura dei Tumori Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
